• Activity INFORMATION

  Overview

  While benzodiazepines do not get the same level of drug-harm publicity that opioids do, they still pose a significant public health threat due to medication harm. Despite over 60 years of market availability, much still needs to be learned regarding which patients should be prescribed these medications and when and how they can appropriately be deprescribed. In attending this program, participants will learn both appropriate prescribing and deprescribing techniques. They will also interact with a patient case and learn how to facilitate positive conversations regarding benzodiazepine use and tapering.
  

  Handouts

  • Slide Document :   23144H01_2pp.pdf Download

  • Slide Document :   23144H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recognize appropriate guidance for prescribing and the systems in place for deprescribing

  Recognize elements of effective patient communications in regard to benzodiazepine use and tapering

  Using a case study, cite appropriate steps for tapering and deprescribing.

  Recall prescribing principles for benzodiazepines and understand diazepam mg equivalents (DME) while identifying its usefulness in deprescribing

  Pharmacy Technician

  Using a case study, cite appropriate steps for tapering and deprescribing.

  Recognize elements of effective patient communications in regard to benzodiazepine use and tapering

  Recognize appropriate guidance for prescribing and the systems in place for deprescribing

  Recall prescribing principles for benzodiazepines and understand diazepam mg equivalents (DME) while identifying its usefulness in deprescribing

  Nurse

  Recall prescribing principles for benzodiazepines and understand diazepam mg equivalents (DME) while identifying its usefulness in deprescribing

  Using a case study, cite appropriate steps for tapering and deprescribing.

  Recognize appropriate guidance for prescribing and the systems in place for deprescribing

  Recognize elements of effective patient communications in regard to benzodiazepine use and tapering

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1112212

  Universal Activity Number

  Pharmacist 0798-0000-23-144-H01-P
  Pharmacy Technician 0798-0000-23-144-H01-T
  Nurse 0798-0000-23-144-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Jolene  Bressi, PharmD, PMP, BCMAS Member, Board of Directors, The Alliance for Benzodiazepine Best Practices

  Lori  Mor, PharmD, BCPS Ambulatory Clinical Pharmacist, Yale New Haven Hospital

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).